US Stock MarketDetailed Quotes

IDEAYA Biosciences (IDYA)

Watchlist
  • 28.980
  • +0.140+0.49%
Close Jun 12 16:00 ET
  • 28.950
  • -0.030-0.10%
Post 20:01 ET
2.74BMarket Cap-18.46P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

IDEAYA Biosciences (IDYA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
6.56M
3,024.43%218.71M
55.37%10.88M
207.83M
0
0
-70.07%7M
78.48%7M
0
0
Operating revenue
--6.56M
3,024.43%218.71M
55.37%10.88M
--207.83M
--0
--0
-70.07%7M
78.48%7M
--0
--0
Cost of revenue
Gross profit
Operating expense
36.40%115.1M
13.19%378.02M
-30.23%105.45M
48.57%99.38M
36.78%88.81M
65.41%84.39M
111.63%333.98M
229.71%151.14M
60.94%66.89M
79.09%64.93M
Selling and administrative expenses
43.51%19.38M
61.11%63.32M
72.04%18.85M
68.25%16.39M
40.27%14.58M
64.43%13.5M
38.85%39.3M
54.97%10.96M
23.88%9.74M
46.91%10.39M
-General and administrative expense
43.51%19.38M
61.11%63.32M
72.04%18.85M
68.25%16.39M
40.27%14.58M
64.43%13.5M
38.85%39.3M
54.97%10.96M
23.88%9.74M
46.91%10.39M
Research and development costs
35.04%95.73M
6.80%314.7M
-38.22%86.6M
45.21%82.99M
36.11%74.23M
65.60%70.89M
127.53%294.67M
261.58%140.18M
69.59%57.15M
86.90%54.53M
Operating profit
-28.62%-108.54M
51.28%-159.31M
34.39%-94.57M
262.13%108.45M
-36.78%-88.81M
-65.41%-84.39M
-143.23%-326.98M
-243.87%-144.14M
-99.53%-66.89M
-98.50%-64.93M
Net non-operating interest income expense
-18.07%10.01M
-13.11%45.62M
-18.29%11.3M
-28.40%10.79M
-6.91%11.32M
6.69%12.21M
144.54%52.5M
73.65%13.83M
147.65%15.07M
154.13%12.16M
Non-operating interest income
-18.07%10.01M
-13.11%45.62M
-18.29%11.3M
-28.40%10.79M
-6.91%11.32M
6.69%12.21M
144.54%52.5M
73.65%13.83M
147.65%15.07M
154.13%12.16M
Other net income (expense)
152.05%773K
Gain on sale of security
----
----
----
----
----
152.05%773K
----
----
----
----
Income before tax
-36.52%-98.54M
58.58%-113.7M
36.10%-83.27M
330.11%119.24M
-46.84%-77.49M
-75.80%-72.18M
-142.98%-274.48M
-283.78%-130.31M
-88.85%-51.82M
-88.97%-52.77M
Income tax
Net income
-36.52%-98.54M
58.58%-113.7M
36.10%-83.27M
330.11%119.24M
-46.84%-77.49M
-75.80%-72.18M
-142.98%-274.48M
-283.78%-130.31M
-88.85%-51.82M
-88.97%-52.77M
Net income continuous Operations
-36.52%-98.54M
58.58%-113.7M
36.10%-83.27M
330.11%119.24M
-46.84%-77.49M
-75.80%-72.18M
-142.98%-274.48M
-283.78%-130.31M
-88.85%-51.82M
-88.97%-52.77M
Minority interest income
Net income attributable to the parent company
-36.52%-98.54M
58.58%-113.7M
36.10%-83.27M
330.11%119.24M
-46.84%-77.49M
-75.80%-72.18M
-142.98%-274.48M
-283.78%-130.31M
-88.85%-51.82M
-88.97%-52.77M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-36.52%-98.54M
58.58%-113.7M
36.10%-83.27M
330.11%119.24M
-46.84%-77.49M
-75.80%-72.18M
-142.98%-274.48M
-283.78%-130.31M
-88.85%-51.82M
-88.97%-52.77M
Basic earnings per share
-35.37%-1.11
61.90%-1.28
36.91%-0.94
325.00%1.35
-29.41%-0.88
-54.72%-0.82
-71.43%-3.36
-186.54%-1.49
-30.43%-0.6
-36.00%-0.68
Diluted earnings per share
-35.37%-1.11
61.90%-1.28
36.91%-0.94
321.67%1.33
-29.41%-0.88
-54.72%-0.82
-71.43%-3.36
-186.54%-1.49
-30.43%-0.6
-36.00%-0.68
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 6.56M3,024.43%218.71M55.37%10.88M207.83M00-70.07%7M78.48%7M00
Operating revenue --6.56M3,024.43%218.71M55.37%10.88M--207.83M--0--0-70.07%7M78.48%7M--0--0
Cost of revenue
Gross profit
Operating expense 36.40%115.1M13.19%378.02M-30.23%105.45M48.57%99.38M36.78%88.81M65.41%84.39M111.63%333.98M229.71%151.14M60.94%66.89M79.09%64.93M
Selling and administrative expenses 43.51%19.38M61.11%63.32M72.04%18.85M68.25%16.39M40.27%14.58M64.43%13.5M38.85%39.3M54.97%10.96M23.88%9.74M46.91%10.39M
-General and administrative expense 43.51%19.38M61.11%63.32M72.04%18.85M68.25%16.39M40.27%14.58M64.43%13.5M38.85%39.3M54.97%10.96M23.88%9.74M46.91%10.39M
Research and development costs 35.04%95.73M6.80%314.7M-38.22%86.6M45.21%82.99M36.11%74.23M65.60%70.89M127.53%294.67M261.58%140.18M69.59%57.15M86.90%54.53M
Operating profit -28.62%-108.54M51.28%-159.31M34.39%-94.57M262.13%108.45M-36.78%-88.81M-65.41%-84.39M-143.23%-326.98M-243.87%-144.14M-99.53%-66.89M-98.50%-64.93M
Net non-operating interest income expense -18.07%10.01M-13.11%45.62M-18.29%11.3M-28.40%10.79M-6.91%11.32M6.69%12.21M144.54%52.5M73.65%13.83M147.65%15.07M154.13%12.16M
Non-operating interest income -18.07%10.01M-13.11%45.62M-18.29%11.3M-28.40%10.79M-6.91%11.32M6.69%12.21M144.54%52.5M73.65%13.83M147.65%15.07M154.13%12.16M
Other net income (expense) 152.05%773K
Gain on sale of security --------------------152.05%773K----------------
Income before tax -36.52%-98.54M58.58%-113.7M36.10%-83.27M330.11%119.24M-46.84%-77.49M-75.80%-72.18M-142.98%-274.48M-283.78%-130.31M-88.85%-51.82M-88.97%-52.77M
Income tax
Net income -36.52%-98.54M58.58%-113.7M36.10%-83.27M330.11%119.24M-46.84%-77.49M-75.80%-72.18M-142.98%-274.48M-283.78%-130.31M-88.85%-51.82M-88.97%-52.77M
Net income continuous Operations -36.52%-98.54M58.58%-113.7M36.10%-83.27M330.11%119.24M-46.84%-77.49M-75.80%-72.18M-142.98%-274.48M-283.78%-130.31M-88.85%-51.82M-88.97%-52.77M
Minority interest income
Net income attributable to the parent company -36.52%-98.54M58.58%-113.7M36.10%-83.27M330.11%119.24M-46.84%-77.49M-75.80%-72.18M-142.98%-274.48M-283.78%-130.31M-88.85%-51.82M-88.97%-52.77M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -36.52%-98.54M58.58%-113.7M36.10%-83.27M330.11%119.24M-46.84%-77.49M-75.80%-72.18M-142.98%-274.48M-283.78%-130.31M-88.85%-51.82M-88.97%-52.77M
Basic earnings per share -35.37%-1.1161.90%-1.2836.91%-0.94325.00%1.35-29.41%-0.88-54.72%-0.82-71.43%-3.36-186.54%-1.49-30.43%-0.6-36.00%-0.68
Diluted earnings per share -35.37%-1.1161.90%-1.2836.91%-0.94321.67%1.33-29.41%-0.88-54.72%-0.82-71.43%-3.36-186.54%-1.49-30.43%-0.6-36.00%-0.68
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +11.05%
Sample Name
Sample Code
 +1.03%
Sample Name
Sample Code
 -2.29%
4
VanEck Oil Services ETF
OIH
-3.00%
5
ProShares Ultra Energy
DIG
-3.15%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.02%
Sample Name
Sample Code
 +9.96%
Sample Name
Sample Code
 +9.80%
4
Qifu Technology
QFIN
+5.99%
5
Futu Holdings Ltd
FUTU
+5.64%
View More
Middle East conflict spreads to the stock market! How should investors respond?
The U.S.-Iran peace talks have entered a critical window! On the 14th, Iranian sources indicated that Pakistan will host a video conference Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -